YSB Inc. (9885.HK)

HKD 5.95

(1.02%)

Market Cap (In HKD)

4.01 Billion

Revenue (In HKD)

16.97 Billion

Net Income (In HKD)

-3.2 Billion

Avg. Volume

967.52 Thousand

Currency
HKD
Country
Open
-
Prev. Close
-
Day Range
-
Year Range
5.37-10.98
PE
-
EPS
-
Beta Value
0.0
ISIN
KYG9879S1003
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Industry
CEO
Mr. Buzhen Zhang
Employee Count
-
Website
https://www.ysbang.cn
Ipo Date
2023-06-28
Details
YSB Inc. develops digital pharmaceutical platform for pharmaceutical companies, distributors, vendors, pharmacies, and primary healthcare institutions in China. It develops ClouDiagnos for diagnostic testing service; wePharmacy, a 24-hour access smart unmanned pharmaceutical booth that connects buyers and the end customers with pharmacist services; SaaS solutions; and YSB eLearn that provides online courses for the preparation of the pharmacist qualification examinations. The company also engages in the wholesale and retail of pharmaceutical and healthcare products. In addition, it provides medical testing services. The company was founded in 2015 and is headquartered in Guangzhou, China.